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Malnutrition is an umbrella term that includes starvation, sarcopenia, and cachexia; however, diﬀerentiating between these terms
is infrequent in clinical practice. Given that the eﬀectiveness of treatment depends on the aetiology of unintentional weight loss,
it is important that clinicians are aware of the deﬁning characteristics. The aim of this study was to determine whether Australian
dietitians understand and use the terms starvation, sarcopenia, and cachexia and provide targeted treatment strategies accordingly.
Members of the Dietitians Association of Australia were surveyed to gain information on practices and attitudes to diagnosis and
treatment of adult malnutrition. In addition, three case studies were provided to examine understanding of starvation, sarcopenia,
and cachexia. 221 dietitians accessed the survey. 81 respondents (43%) indicated the use of at least one alternate term (starvation,
sarcopenia, and/or cachexia). Muscle wasting was the most commonly used diagnostic criterion. High-energy high-protein diet
was the most common therapy prescribed. Correct diagnoses for case studies were recorded by 6% of respondents for starvation,
46% for sarcopenia, and 21% for cachexia. There is a need for increased awareness of the existence of starvation, sarcopenia, and
cachexia amongst Australian dietitians and research into appropriate methods of identiﬁcation and treatment for each condition.
1.Introduction
Recent literature has reﬁned the umbrella term malnutrition
to include such conditions as starvation, sarcopenia, and
cachexia [1–3]. In recent years, several consensus deﬁnitions
for the diagnosis of sarcopenia [1, 4] and cachexia [1, 5]h a v e
been published, however, there is no indication that further
work has been conducted to validate any of these deﬁnitions.
Consequently, there is still confusion over the diagnosis of
these conditions as there are no universally shared criteria.
However, indications are that simple starvation is the loss
of fat and fat-free mass which occurs purely as a result of
protein-energy deﬁciency; sarcopenia is the loss of muscle
massandmusclestrengthwhichoccurswithageing;cachexia
is severe wasting, predominantly of fat-free mass, driven by
inﬂammation [4–7].
Guidelines used in practice, including the Dietitians
Association of Australia (DAA) endorsed “Evidence-based
practice guidelines for the nutritional management of mal-
nutrition in adult patients across the continuum of care,”
invariablytakeasimplisticapproachtomalnutritionthrough
focusing on protein-energy malnutrition, or starvation,
alone[2,7,8].Theimplicationsofthescarcityofrecommen-
dations for identiﬁcation and treatment of alternate malnu-
trition conditions (sarcopenia and cachexia) are potential
misdiagnosis and treatment, and ultimately suboptimal
health outcomes.
While increased energy and protein intake may be the
principal, and most appropriate, intervention for treatment
of starvation, it is becoming clear that conditions such as
sarcopenia and cachexia cannot be reversed by increased
dietary intake alone [9]. Investigation into pharmacological
therapies for sarcopenia has not provided strong evidence
for eﬃcacy, however, there is support for resistance training,
in addition to adequate energy and protein intake, as a
safe and eﬀective therapy [10]. Considerable research has2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
b e e nc o n d u c t e di na ne ﬀort to ﬁnd an eﬀective therapy for
cachexia. Potential interventions include megestrol acetate
[11],ghrelin[12],andﬁshoil[13],however,successhasbeen
limited and research is continuing.
In the battle to combat malnutrition dietitians, are in the
frontline yet the success of their practice could be limited
unless they are armed with the correct knowledge in terms of
identiﬁcation and appropriate treatment strategies. The aim
of this project was to determine whether dietitians under-
stand and use the terms starvation, sarcopenia, and cachexia
and provide targeted treatment strategies accordingly.
2.MaterialsandMethods
An anonymous cross-sectional survey of members of the
DAA was undertaken to gain information on their attitudes
and practices regarding the diagnosis and treatment of
malnutrition in adults. All members are required to have
graduated from a tertiary program designed to achieve entry
levelcompetenciesasprescribedbytheDAA.Membersofthe
DAA,includingstudentmembers,wereinvitedtoparticipate
via weekly email distribution from DAA national oﬃce, in
August 2010. The email notiﬁed of the presence of a link to
an online questionnaire and provided a brief introduction
to the survey to enable prospective participants to gauge
their level of interest in the project. Upon entering the
web-based survey, participants were provided with further
background. At the time of the survey, the DAA website
indicated a potential pool of approximately 4000 members,
and all were eligible to participate in the survey. Researchers
were blinded to respondents’ identities. The protocol for this
research project was approved by the Social and Behavioural
Research Ethics Committee of Flinders University, Adelaide,
South Australia, and conforms to the provisions of the
Declaration of Helsinki (as revised in Edinburgh 2008).
Informed consent was implied upon completion of the
survey. This study was registered on the Australian New
Zealand Clinical Trials Registry (ACTRN12610000403033).
Following a review of the current literature on identiﬁca-
tion and classiﬁcation of categories of malnutrition, includ-
ing relevant consensus deﬁnitions [1, 4, 5], a questionnaire
was drafted by the authors using an online survey facility
(SurveyMonkey, Palo Alto, Calif, USA). The tool was piloted
on a small group of clinical dietitians and subsequently
amended to reﬂect their comments where necessary. The
ﬁnal web-based questionnaire comprised a maximum of
42 questions (some conditional release), depending on
responses given (see Table 1), and was available online from
August-September2010.Participantswereaskedtocomplete
the survey by selecting appropriate answers from random-
ordered lists provided and by giving further comment
where necessary. A copy of the survey is available from the
corresponding author on request.
Demographic information collected included age, gen-
der, years of practice, and location. In order to ascertain
current practice and use of terminology, respondents were
asked to provide information on criteria for diagnosis,
exposure to malnourished patients, use of the terms starva-
tion, sarcopenia, and/or cachexia and criteria for diagnosis
of any categories used. Three case studies were provided;
one describing a patient in each of the three categories of
malnutrition of interest, according to current literature [1, 5,
9], and respondents were asked to provide a diagnosis based
on information given. Treatment regimes were investigated
in a question asking respondents to rank ten possible
interventions for malnutrition, from one to ten. Further
investigation was then conducted into the use of speciﬁc
interventions (ﬁsh oil, appetite stimulants, and resistance
training), which have been investigated as potential therapies
for sarcopenia and cachexia [10, 14, 15].
Survey responses were analysed using SurveyMonkey,
and IBM SPSS Statistics, version 19.0.0 [16]. Descriptive
statistics were reported as frequencies (n) and percentages
(%). Chi-squared tests were used to compare case study
responses for selected subgroups of study participants.
Statistical signiﬁcance was set at P<0.05.
3. Results
Two hundred and twenty-one DAA members, including ten
student members, accessed the web-based survey during
the data collection period, representing a response rate of
approximately 5.5%. Of those, 209 (95%) provided full
demographic details and 205 (93%) continued to the main
partofthesurvey.Intotal,169(76%)respondentscompleted
the entire survey.
Respondent characteristics are reported in Table 2.
ResponseswerereceivedfromallstatesandterritoriesinAus-
tralia, with the majority from Victoria (30%) and New South
Wales (30%). Almost half of respondents worked in the
publichospitalsystem(49%)andone-quarterreportedsome
work in private practice (25%). Ninety percent reported
working with adult patients.
Around 40% of survey participants reported seeing 2–5
malnourished adults each week, with some reporting that
they consulted ≥10, particularly in the aged care setting.
With regard to terminology to describe categories of mal-
nutrition, 81 respondents (43%) indicated that they used at
leastoneofthetermsstarvation,sarcopenia,and/orcachexia.
Of those, most used cachexia (89%), followed by starvation
(31%) and sarcopenia (19%). Six (7%) individuals reported
use of all three terms in their practice.
The most common criteria for diagnosis of malnutrition
were reported to be muscle wasting (86%), loss of subcu-
taneous fat (81%), weight loss (77%), decreased appetite
(76%), BMI < 18.5kg/m2 (<22kg/m2 for those aged 65+
years) (67%), and anorexia (65%). For respondents report-
ing that they used the term starvation, the top three criteria
used to diagnose this condition were muscle wasting (38%),
anorexia (36%), and low BMI (36%). For respondents
reporting that they used the term sarcopenia, the top three
criteria used to diagnose this condition were muscle wasting
(31%),lossofmusclestrength(28%),andweightloss(16%).
For respondents reporting that they used the term cachexia,
the top three criteria used to diagnose this condition were
muscle wasting (76%), loss of subcutaneous fat (74%), and
anorexia (69%).J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
Table 1: Details of online questionnaire used to survey DAA members on perspectives on malnutrition.
Topic Maximum number
of questions Response format Examples of content
Demographic questions 11 Yes/no tick boxes; 2–8 tick boxes per
question; space for comments
Age; gender; number of years of
experience; employment status
Diagnosis of malnutrition 10 Yes/no tick boxes; 2–16 tick boxes per
question; space for comments
ICD criteria for malnutrition; choice of
markers for diagnosis of malnutrition;
use of the terms starvation, sarcopenia
and/or cachexia; choice of markers for
diagnosis of starvation, sarcopenia
and/or cachexia, if used
Case studies 3 4 tick boxes per question; space for
comments
One case study for each of starvation,
sarcopenia and cachexia
Treatment of malnutrition 12
Choice of 10 possible interventions to be
ranked 1–10; yes/no tick boxes; 5-6 tick
boxes per question; space for comments
Choice of possible interventions; further
questions on speciﬁc interventions:
appetite stimulants, ﬁsh oil, and
resistance training
Barriers to eﬀective treatment of
malnutrition 1 Open-ended; space for comment
Guidelines for treatment of
malnutrition 3 Yes/no tick boxes; space for comment DAA guidelines; other guidelines used
Total 40†
†A further two questions asked the participant about their desire to continue in order to ascertain the correct path through the questionnaire.
DAA: Dietitians Association of Australia.
When responding to the case study questions, the major-
ity of respondents (77%, 63%) used the term malnutrition
to refer to what were clear cases of starvation and cachexia,
respectively.Thecorrectdiagnosisofstarvationwasrecorded
by 6% of respondents; 46% of respondents correctly identi-
ﬁed the sarcopenia case; 21% correctly identiﬁed cachexia.
When case study responses were examined according to
years of dietetic experience, more respondents with 5 or less
years of experience correctly identiﬁed the condition in each
case study, however these diﬀerences were not statistically
signiﬁcant (see Table 3).
When participants were asked to rank, from 1 to 10,
a range of possible interventions to treat malnutrition,
according to their own criteria, the most frequently selected
therapies were high-energy high-protein diet (75% of
respondents), high-energy high-protein snacks (48%), oral
nutritional supplements (42%), and enteral feeds (32%).
Three selected therapies were further investigated: 21%
of respondents have recommended appetite stimulants to
patients, 45% have recommended ﬁsh oil, and 57% have
recommended resistance training. However, survey respon-
dents reported that very few patients received such a recom-
mendation. Fifty percent of those recommending appetite
stimulants indicated that this recommendation was for less
than 5% of patients. Similarly, 64% of those recommending
ﬁsh oil, and 46% of those recommending resistance training,
did so to less than 5% of their patients.
Most commonly, respondents referred patients for pre-
scription appetite stimulants (56%) and referred to a physio-
therapist for resistance training (71%) but made their own
recommendations for ﬁsh oil. Fish oil was proposed most
often for high cholesterol (75%) and rheumatoid arthritis
(71%), with most respondents advising a daily dosage of
1g of omega-3 fatty acids per day. Twenty six percent of
study participants recommended ﬁsh oil as an intervention
for malnutrition.
4. Discussion
The results from this cross-sectional survey provide insight
into the inconsistency in the understanding and use of
the terms starvation, sarcopenia, and cachexia amongst
Australian dietitians. Furthermore, it appears that treatment
strategies are generally focused on improving energy and
protein intake, a strategy that alone is known to be largely
ineﬀective in the treatment of cachexia and sarcopenia [7,
10].
Alternative terminology for diﬀerent categories of mal-
nutrition was not widely used amongst Australian dietitians,
with less than half of respondents using any of the terms
starvation, sarcopenia, and/or cachexia. While the recently
released DAA endorsed “Evidence based practice guidelines
for the nutritional management of malnutrition in adult
patients across the continuum of care” are explicit in their
reference to protein-energy under nutrition only [8]; other
commonly used guidelines and tools do not diﬀerentiate
between categories of malnutrition [17–19], therefore they
do not provide dietitians with the necessary guidance to
correctly diagnose diﬀerent malnutrition conditions.
Those who use the terms starvation, sarcopenia and/or
cachexia do not appear to be consistent in using the most
accepted criteria as part of their diagnosis. Simple starvation
is unintentional weight loss, with predominant loss of fat
mass, purely as a result of inadequate protein and energy
intake [3], yet 38% of respondents indicated that muscle
wasting was the key criterion for diagnosis, more than4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Table 2: Characteristics of 221 respondents to a web-based survey
ofcurrentattitudesandpracticesofmembersoftheDAA,inregards
to diagnosis and current dietary management of malnutrition.
Female
(n = 215)
Male
(n = 6)
Gender (n = 221) 97.3% 2.7%
Age
(i) 21–30 years 51.6% 33.3%
(ii) 31–40 years 26.0% 33.3%
(iii) 41–50 years 14.0% 16.7%
(iv) 51–60 years 6.5% 16.7%
(v) >60 years 1.9%
Employment status
(i) Full time 65.1% 83.3%
(ii) Part time (<20 hours per week) 16.3% 16.7%
(iii) Student dietitian 4.7%
(iv) Locum 2.3%
(v) Further study 0.9%
(vi) Unrelated industry 0.9%
(vii) Not working 1.9%
(viii) Retired 0.5%
(ix) Other 7.4%
Dietetic experience
(i) <1 year 8.4%
(ii) 1–5 years 35.3% 66.7%
(iii) 6–10 years 19.5% 16.7%
(iv) 11–20 years 18.1% 16.7%
(v) >20 years 14.0%
Work location
(i) Metropolitan/urban 63.3% 50.0%
(ii) Regional/rural/remote 27.4% 33.3%
(iii) Both of the above 4.2% 16.7%
Primary practice setting
(i) Public hospital 47.8% 83.3%
(ii) Community health 21.5% 16.7%
(iii) Private hospital 4.4%
(iv) Private practice† 10.2%
(v) Other 16.1%
†A further 15.2% of respondents reported part-time private practice.
DAA: Dietitians Association of Australia.
reduced BMI or weight loss. The key characteristics of
cachexia are elevated inﬂammatory markers and reduced
body cell mass [9], so while 76% of respondents indicated
that muscle wasting was their key criterion for diagnosis,
only 24% would consider elevated inﬂammatory mark-
ers. Sarcopenia is characterised by reduced muscle mass,
strength, and function [1, 4], and 76% of survey participants
indicated that muscle wasting was again the key criterion,
but 50% of respondents indicated that muscle strength was
a consideration hence this appears to indicate a clearer
understanding of sarcopenia amongst Australian dietitians.
Ability to identify the three conditions from case study
information was poor, with 6% of respondents able to
correctly diagnose starvation, 46% sarcopenia, and 21%
Table 3: Case study responses reported by respondents to a web-
based survey of current attitudes and practices of members of the
DAA, in regards to diagnosis and current dietary management of
malnutrition, according to years of dietetic experience (n/%).
<1–5 years 6+ years
Case study 1: Cachexia
(i) Malnutrition 56 (62%) 61 (66%)
(ii) Starvation 0 (0%) 0 (0%)
(iii) Sarcopenia 5 (6%) 4 (4%)
(iv) Cachexia 21 (23%) 17 (18.3)
Case study 2: Starvation
(i)Malnutrition 69 (78%) 72 (78%)
(ii) Starvation 8( 9 %) 3( 3 % )
(iii) Sarcopenia 2 (2%) 5 (5%)
(iv) Cachexia 6 (7%) 7 (8%)
Case study 3: Sarcopenia
(i) Malnutrition 28 (33%) 31 (34%)
(ii) Starvation 4 (5%) 5 (6%)
(iii) Sarcopenia 44 (52%) 34 (37%)
(iv) Cachexia 4 (5%) 11 (12%)
n:n u m b e r .
cachexia. This gives further indication that dietitians are
more familiar with sarcopenia than either starvation or
cachexia and suggests that there is a need to increase the
awareness among dietitians of the existence of separate cate-
gories of malnutrition and to educate on alternate diagnoses.
H o w e v e r ,f o re a c hc a s es t u d y ,m o r en e w e rg r a d u a t e s( 5o r
less years of experience) than those with 6 or more years
of experience, correctly identiﬁed the diﬀerent categories of
malnutrition. Although this did not reach statistical signiﬁ-
cance it does suggest that these categories may receive more
attention in current university curriculums. It is noteworthy
that 63% of respondents to the cachexia case study indicated
a diagnosis of malnutrition. While this is technically not
incorrect as all cachectic patients are malnourished, the case
study provided information on inﬂammatory status which
should have alerted dietitians to the presence of cachexia [1].
The inconsistency identiﬁed in the understanding and
application of the terms sarcopenia, starvation, and cachexia
extended to the interventions used to treat patients/clients.
Therapy for malnutrition was predominantly centred on
increased energy and protein intake with most dietitians
prescribing high-energy high-protein diet, snacks and/or
enteral feeds. However, the literature indicates that the
deﬁning characteristic of starvation is that it is reversed
by increased protein and energy intake, unlike sarcopenia
or cachexia, therefore, provision of standard interventions,
regardless of the aetiology of malnutrition is likely to address
starvation alone.
There are some limitations which should be considered
intheinterpretationofthedatafromthissurvey.Participants
were from Australia and it should be acknowledged that
the ﬁndings may diﬀer elsewhere and therefore a repeat
survey of dietitians from other countries would be valuable.J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
The sample size may be considered small, however the
response rate was similar to the expected level of response
to surveys previously delivered by the organisation (DAA
national oﬃce, personal communication, 2010). It is also
noteworthy that the majority of respondents were young
and had been practicing for a short time and worked
in metropolitan public hospitals. This proﬁle reﬂects the
workforce statistics for dietitians in Australia (DAA national
oﬃce, personal communication, 2010). Finally, the diagnos-
ticcriteriausedinthequestionnairewerebasedonconsensus
deﬁnitions which have not yet been validated however they
were developed by leading experts in the ﬁeld and are
therefore likely to be proved to be valid and reliable in future
work.
Further investigation into three interventions previously
researched for use in diﬀerent categories of malnutrition
revealed that appetite stimulants, ﬁsh oil, and resistance
training are not widely recommended to malnourished
patients. Recent research has shown that these interventions
can be helpful in conjunction with adequate energy and
protein intake to address sarcopenia and cachexia, which
are unlikely to resolve purely with increased nutritional
intake [10, 14, 15]. However, currently used guidelines for
treatmentofmalnutrition do not advocate targetedtherapies
for malnutrition [8, 17, 19] thus do not provide dietitians
with the correct advice to deliver optimal health outcomes to
patients.
In conclusion, the results of this study indicate a need for
increased awareness of starvation, sarcopenia, cachexia, and
appropriate methods of identiﬁcation and treatment. More
work is warranted to explore how dietitians might expand
existing or collaborate to develop new screening and/or
assessment tools to assist in diﬀerentiating the three distinct
conditions, contribute to the evidence base for appropriate
treatment strategies, and determine the cost eﬀectiveness of
this change in practice.
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